DETAILED NOTES ON BI8622

Dosages need to be individualized based on the advisable goal of therapy as well as affected person’s response.Rhabdomyolysis with renal dysfunction secondary to myoglobinuria happen to be noted with other HMG-CoA reductase inhibitors. This has not been reported with cerivastatin sodium thus far. Cerivastatin therapy must be discontinued if marke